Tenaya Therapeutics Inc [TNYA] stock is trading at $5.16, up 6.83%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TNYA shares have gain 5.31% over the last week, with a monthly amount drifted -11.64%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 18, March 2024, Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update. In a post published today on Yahoo Finance, Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second Half of 2024.
From an analyst’s perspective:
Tenaya Therapeutics Inc [NASDAQ: TNYA] stock has seen the most recent analyst activity on November 30, 2023, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $7. Previously, H.C. Wainwright started tracking the stock with Buy rating on June 15, 2022, and set its price target to $25.
Tenaya Therapeutics Inc [TNYA] stock has fluctuated between $1.66 and $8.09 over the past year. Tenaya Therapeutics Inc [NASDAQ: TNYA] shares were valued at $5.16 at the most recent close of the market.
Analyzing the TNYA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.73, Equity is -0.7 and Total Capital is -0.89. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.84 points at the first support level, and at 4.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.38, and for the 2nd resistance point, it is at 5.61.
Tenaya Therapeutics Inc [TNYA] reported earnings per share of -$0.4 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.44/share, meaning a difference of $0.04 and a surprise factor of 9.10%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.39 per share as compared to estimates of -$0.47 per share, a difference of $0.08 representing a surprise of 17.00%.
Ratios To Look Out For
For context, Tenaya Therapeutics Inc’s Current Ratio is 4.91. Also, the Quick Ratio is 4.91, while the Cash Ratio stands at 2.01.
Transactions by insiders
Recent insider trading involved Hoey Timothy, Chief Scientific Officer, that happened on Mar 05 ’24 when 3300.0 shares were sold. Chief Scientific Officer, Hoey Timothy completed a deal on Feb 20 ’24 to sell 6569.0 shares. Meanwhile, Chief Medical Officer Tingley Whittemore sold 6500.0 shares on Feb 16 ’24.
